Overview
Curaleaf Poland is a licensed pharmaceutical wholesaler specializing in the acquisition, registration, and distribution of medical cannabis products for prescription use. The company provides pharmacies with access to a range of cannabis-based medicines, including dried and extract products containing THC and cannabinoids, all manufactured under GMP conditions. Curaleaf Poland focuses on expanding patient access to high-quality medical cannabis in the growing market since its legalization in 2017.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Curaleaf Education Launches in Poland with free, localised resources for Healthcare Professionals
LONDON, Oct. 8, 2026- Curaleaf International has announced the launch of the Curaleaf Education Platform in Poland, giving healthcare professionals across
A regulatory first in Australia and a new market in New Zealand
LONDON, Oct. 2, 2026 /PRNewswire/ -- Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in partnership with Jupiter Research LLC, today
Milestone reinforces Curaleaf’s leadership in emerging international markets
STAMFORD, Conn., July 13, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international
Curaleaf International Launches CPD-Accredited Medical Cannabis Education Platform for UK Healthcare Professionals
London, 23 June 2026: Curaleaf International, one of the global leaders in medical cannabis, today announces the launch of the Curaleaf Education
From cultivation to conference: how science and supply chain shape medical cannabis future
There is something remarkable about a room full of people at Cannabis Europa. Lawyers and laboratory scientists stand next to pharmacists and financial
Reflections from ANZCCP, Australia
This year's ANZCCP delivered some strong themes that resonated closely with where we are as a business. The clearest signal across the event was a shift
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-12-24. Active
64 1020 5226 0000 6602 0637 5218- 81 1020 5226 0000 6202 0738 8855
- 89 1020 5226 0000 6602 0723 3218
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 18, 2023 | Transformation |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 26, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,131$1,131 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Trademarks
Curaleaf Poland holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.
| Mark | Protected until | |
|---|---|---|
| CAN4MED | Nov 24, 2033 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the President of the Management Board. In the case of a management board consisting of two or more members, declarations of will on behalf of the company may be made by the President of the Management Board or the Vice-President of the Management Board independently, or joint action by a member of the management board together with a commercial proxy is required.
Supervisory board
Ownership
| Owner |
|---|
Curaleaf International Limited |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl | ||
| CarnexS.K.A. | $4,618,202.74 | carnex.pl | ||
| Imarti Poland sp. z o.o.sp. k. | $4,030,681.15 | imarti.eu | ||
| Polska Grupa Farmaceutycznasp. z o.o. | $3,192,376.31 | pgflomza.pl | ||
| Steriwundsp. z o.o. | $2,832,891.51 | steriwund.pl | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | ||
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Passimedsp. z o.o. | $1,677,642.39 | passimed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-22 | Name change (Can4med → Curaleaf Poland) | |
| 2023-01-02 | Entered in the register |
FAQ
Last updated: 2026-07-31